Sophie Georgia Tillotson

Dr. Sophie Georgia Tillotson


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2025 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Closed access
DSDanielle L. Snyder
Danielle L. Snyder
SSSilvana Sidhom
Silvana Sidhom
CCCorinne E. Chatham
Corinne E. Chatham
STSophie Georgia Tillotson
Sophie Georgia Tillotson
RZRuben D. Zapata
Ruben D. Zapata
NMNash S. Moawad
Nash S. Moawad

10 April 2025 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
SSSiddharth Shah
Siddharth Shah
AAAmelia H. Alberts
Amelia H. Alberts
STSophie Georgia Tillotson
Sophie Georgia Tillotson
HJHritvik Jain
Hritvik Jain
Brandon Lucke-WoldBrandon Lucke-Wold
Brandon Lucke-Wold

4 October 2025 in Reproductive Medicine
Verified
Journal Article
Open access
PDF file
AIAmelia Curtis Inclan
Amelia Curtis Inclan
DSDanielle Lynn Snyder
Danielle Lynn Snyder
STSophie Georgia Tillotson
Sophie Georgia Tillotson
KFKatelyn E. Flaherty
Katelyn E. Flaherty
ABAngelica Noelle Byrd
Angelica Noelle Byrd
CCCharlotte Chaiklin
Charlotte Chaiklin
Primary care providers are increasingly tasked with providing basic gynecologic care, including contraceptive therapy, to their patients. In the United States, oral contraceptive pills are the most frequently prescribed form of contraception; thus, it is critical that primary care providers are well versed in addressing common patient questions. Well-documented concerns relating to oral contraception initiation include changes in weight, mood, cancer risk, libido, acne, and infertility. Herein, we provide a clinical case example of a patient with these common concerns, review the related evidence, and suggest appropriate counseling with the goal of helping primary care clinicians provide the highest level of evidence-based oral contraceptive care.

1 November 2024 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
STSophie Georgia Tillotson
Sophie Georgia Tillotson
PSPing Shi
Ping Shi
ERElizabeth Ray
Elizabeth Ray
RSRobert P Seifert
Robert P Seifert
Tonsillar marginal zone hyperplasia may mimic mucosa-associated lymphoid tissue lymphoma, a rare diagnosis in children. Histologically, both entities can demonstrate expansion of the marginal zone with disruption of follicular architecture. However, marginal zone hyperplasia may appear polyclonal by flow cytometry. We present two pediatric tonsillectomy cases with tonsillar marginal zone hyperplasia and discuss the diagnostic challenges this poses in the pediatric population. Both tonsillectomies demonstrated expansion of marginal zones with partial architectural effacement, and flow cytometric analysis of both cases detected lambda light chain restricted, CD20(bright) B cells without CD38. Authors have suggested that the lambda restricted B cells in this setting represent naïve, unmutated B cells with preferential, but polyclonal, lambda expression. Our cases are in line with this thought. While robust, BIOMED-2 primer PCR can show dominant IgK peaks, which may be misinterpreted. This presents a diagnostic pitfall in the workup of pediatric tonsils that community pathologists must consider.

27 August 2026 in The American Journal of Bioethics
Verified
Journal Article
Closed access
STSophie Georgia Tillotson
Sophie Georgia Tillotson
JHJamie B. Harris
Jamie B. Harris
LSLauren B. Solberg
Lauren B. Solberg
Johnson et al. (2026) make compelling ethical arguments for limiting antibiotic use to the shortest effective duration, but chronic dermatologic conditions introduce additional considerations that ...